| Ixazomib studied in …STUDIED_INderived114 of 114show fewer |
|---|
| → studied in | NCT02619682Phase 2 · completed Alternating Ixazomib Citrate and Lenalidomide as Maintenance Therapy After Stem Cell Transplant in Treating Patients With Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma,Transplant-Related Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587662Phase 2 · completed Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer · 114 trials list this drug (18 active) | — | — | Renal Cell Carcinoma,Kidney Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04847453Phase 1 · active not recruiting Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis · 114 trials list this drug (18 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02343042Phase 1/Phase 2 · recruiting Selinexor and Backbone Treatments of Multiple Myeloma Patients · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451771Phase 1/Phase 2 · active not recruiting Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis · 114 trials list this drug (18 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03283917Phase 1 · completed Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis · 114 trials list this drug (18 active) | — | — | Primary Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339922Phase 2 · active not recruiting Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma · 114 trials list this drug (18 active) | — | — | Chronic Lymphocytic Leukemia,Small Lymphocytic Lymphoma,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03323151Phase 1/Phase 2 · completed A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma · 114 trials list this drug (18 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04068597Phase 1/Phase 2 · recruiting Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies · 114 trials list this drug (18 active) | — | — | Multiple Myeloma,Non-Hodgkin Lymphoma,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01415882Phase 2 · completed Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03651128Phase 3 · completed Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04998786Phase 2 · active not recruiting A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse." · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03547700Phase 1/Phase 2 · terminated Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL) · 114 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03506373Phase 2 · terminated Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia · 114 trials list this drug (18 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173092Phase 4 · terminated A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM) · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03763162Phase 2 · active not recruiting Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04094961Phase 1/Phase 2 · active not recruiting Ixazomib + Pomalidomide + Dexamethasone In MM · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04305691Phase 2 · recruiting Trial of Ixazomib for Kaposi Sarcoma · 114 trials list this drug (18 active) | — | — | Kaposi Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02389517Phase 2 · completed Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05722405Phase 4 · recruiting Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04009109Phase 2 · active not recruiting Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02461888Phase 2 · completed Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma. · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03618537Phase 2 · active not recruiting Ixazomib Maintenance Study in Patients With AL Amyloidosis · 114 trials list this drug (18 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02253316Phase 2 · active not recruiting Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420847Phase 1/Phase 2 · active not recruiting Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery · 114 trials list this drug (18 active) | — | — | Transitional Cell Carcinoma,Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03590652Phase 2 · terminated Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone as Salvage Therapy in Relapsed/Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02412228Phase 2 · completed Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02916771Phase 2 · completed Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01864018Phase 1/Phase 2 · completed Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis · 114 trials list this drug (18 active) | — | — | Multiple Myeloma,Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04052880Phase 2 · active not recruiting Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02765854Phase 2 · completed Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03770260Phase 1 · completed Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not Respond to Treatment · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03817320Phase 1/Phase 2 · active not recruiting PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma · 114 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia,Childhood Acute Lymphoblastic Leukemia,Childhood Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03012880Phase 2 · completed Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03941860Phase 3 · completed Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04047797Phase 2 · terminated Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma · 114 trials list this drug (18 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03376672Phase 2 · active not recruiting Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03748953Phase 3 · completed Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT) · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02924272Phase 2 · completed Ixazomib Rollover Study · 114 trials list this drug (18 active) | — | — | Lymphoma,Multiple Myeloma,Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03457142Phase 2 · terminated Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02921893early Phase 1 · completed Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome · 114 trials list this drug (18 active) | — | — | Plasmacytoma,POEMS Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01718743Phase 2 · completed Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02181413Phase 3 · completed A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06050512Phase 1/Phase 2 · withdrawn Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399539Phase 1 · completed Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02542657Phase 1/Phase 2 · active not recruiting Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02633059Phase 1/Phase 2 · completed Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03225417Phase 1/Phase 2 · unknown Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease. · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04217967Phase 4 · completed Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03439293Phase 2 · completed A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM) · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03942224Phase 2 · unknown Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02697383Phase 1 · completed Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028115Phase 2 · completed Bone Healing During Ninlaro Exposure · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02119468Phase 1/Phase 2 · completed Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03506360Phase 2 · completed Pembrolizumab, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03169361completed NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma" · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03433001completed A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone · 114 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02004275Phase 1/Phase 2 · unknown Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02547662Phase 2 · completed Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia · 114 trials list this drug (18 active) | — | — | Multiple Myeloma,Plasma Cell Leukemia,Plasmacytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03733691Phase 2 · terminated Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03616782Phase 2 · unknown Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL) · 114 trials list this drug (18 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02312258Phase 3 · completed A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03202628Phase 2 · completed Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04079738Phase 1/Phase 2 · terminated Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib · 114 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119336Phase 2 · terminated Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01850524Phase 3 · completed IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02632396Phase 1/Phase 2 · unknown Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission · 114 trials list this drug (18 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02942095Phase 1 · completed Study of Ixazomib and Erlotinib in Solid Tumors · 114 trials list this drug (18 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01564537Phase 3 · completed A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02440464Phase 2 · completed Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302) · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170882Phase 2 · completed A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma · 114 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03236792Phase 1/Phase 2 · completed Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis · 114 trials list this drug (18 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03082677Phase 2 · completed Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies · 114 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03416374Phase 4 · completed A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy · 114 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02898259Phase 1/Phase 2 · terminated Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma · 114 trials list this drug (18 active) | — | — | B-Cell Malignant Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05183139Phase 4 · withdrawn A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02481310Phase 1/Phase 2 · unknown Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma · 114 trials list this drug (18 active) | — | — | Diffuse Large B-Cell Lymphoma,Adult Burkitt Lymphoma,Plasmablastic Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02499081Phase 2 · completed UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02630030early Phase 1 · completed Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma · 114 trials list this drug (18 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02917941Phase 2 · completed A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02993094Phase 1/Phase 2 · terminated Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer · 114 trials list this drug (18 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03880123Phase 1 · withdrawn Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma · 114 trials list this drug (18 active) | — | — | Sarcoma,Ewing Sarcoma,Liposarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831686Phase 1 · completed A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02504359Phase 1 · completed Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma,Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02897830Phase 2 · terminated Ixazomib, Lenalidomide, Dexamethasone Induction and Extended Consolidation Plus Lenalidomide Maintenance in Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03888534Phase 1 · withdrawn Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy) · 114 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02400437Phase 2 · completed Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia · 114 trials list this drug (18 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01953783Phase 1 · completed Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB · 114 trials list this drug (18 active) | — | — | Solid Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03669445Phase 2 · unknown Study Association of Lenalidomide, Ixazomib, Dexamethasone and Daratumumab in Newly Diagnosed Standard Risk Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03492138Phase 1/Phase 2 · terminated Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01318902Phase 1 · completed Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis · 114 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272775Phase 1 · terminated A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) · 114 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03608501Phase 2 · withdrawn A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02410694Phase 2 · completed Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01939899Phase 2 · completed Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular Lymphoma · 114 trials list this drug (18 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02447887Phase 1/Phase 2 · terminated Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) · 114 trials list this drug (18 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00830869Phase 1 · completed A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies · 114 trials list this drug (18 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00932698Phase 1 · completed Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02046070Phase 2 · completed Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01830816Phase 1 · completed Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment · 114 trials list this drug (18 active) | — | — | Solid Neoplasm,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02030405Phase 2 · terminated Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 114 trials list this drug (18 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03856112Phase 1/Phase 2 · withdrawn Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01383928Phase 1/Phase 2 · completed Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02070458Phase 1 · completed Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia · 114 trials list this drug (18 active) | — | — | Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01645930Phase 1 · completed Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02302846Phase 2 · terminated Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission · 114 trials list this drug (18 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01217957Phase 1/Phase 2 · completed A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02578511Phase 1 · withdrawn Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR) · 114 trials list this drug (18 active) | — | — | Acute Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Mixed Phenotype Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01335685Phase 1/Phase 2 · completed Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00963820Phase 1 · completed Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple Myeloma · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01454076Phase 1 · completed Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma · 114 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02578121Phase 2 · withdrawn UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination · 114 trials list this drug (18 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01912222Phase 1 · completed Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction · 114 trials list this drug (18 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00893464Phase 1 · completed A Study of IXAZOMIB in Adult Patients With Lymphoma · 114 trials list this drug (18 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |